Evidence map›Paper›PMID 30348825›Full record

ArticleInfection and immunity2019

Ying-Xia He, Cheng-Lin Ye, Pei Zhang, Qiao Li, Chae Gyu Park, Kun Yang, Ling-Yu Jiang, Yin Lv, Xiao-Ling Ying, Hong-Hui Ding and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Current Challenges inMicroorganisms · 2025
    Review
  7. Access microbiology · 2023
    Article
  8. Review
  9. Mechanisms for the Invasion and Dissemination ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  10. PgtE Enzyme ofFrontiers in immunology · 2022
    Article
  11. Article
  12. Extraintestinal Manifestation ofPathogens (Basel, Switzerland) · 2021
    Article
  13. Lipopolysaccharide of theBiomolecules · 2021
    Review
  14. Loss of the virulence plasmid byJournal of medical microbiology · 2021
    Article
  15. Microorganisms · 2020
    Article
  16. Frontiers in immunology · 2020
    Article
  17. C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens.Frontiers in cellular and infection microbiology · 2020
    Review
  18. Article
  19. Article
  20. Murine SIGNR1 (CD209b) Contributes to the Clearance of UropathogenicFrontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 11 institutions in 6 countries.

Ying-Xia He *Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Cheng-Lin Ye *Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Pei ZhangDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Qiao LiDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Chae Gyu ParkLaboratory of Immunology, Brain Korea 21 PLUS Project for Medical Science, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kun YangDepartment of Pathogen Biology and Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Ling-Yu JiangDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Yin LvDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Xiao-Ling YingDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Hong-Hui DingDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Hong-Ping HuangDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
John Mambwe TemboDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
An-Yi LiDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Bing ChengDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
Shu-Sheng ZhangDepartment of Biomedical Science, College of Medicine-Rockford, University of Illinois at Chicago, Rockford, Illinois, USA.
Guo-Xing ZhengDepartment of Biomedical Science, College of Medicine-Rockford, University of Illinois at Chicago, Rockford, Illinois, USA.
Shi-Yun ChenKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Wei LiDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.ORCID 0000-0002-3257-1540
Lian-Xu XiaDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
Biao KanDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
Xin WangDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
Huai-Qi JingDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
Rui-Fu YangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Hua PengKey Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Yang-Xin FuDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
John D KlenaCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Mikael SkurnikDepartment of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland mikael.skurnik@helsinki.fi chentie@hust.edu.cn.ORCID 0000-0001-8791-9260
Tie ChenDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China mikael.skurnik@helsinki.fi chentie@hust.edu.cn.
Tongji Hospital · CNNational Institute for Communicable Disease Control and Prevention · CNChinese Academy of Sciences · CNRockford University · USCenters for Disease Control and Prevention · USInstitute of Microbiology · CNShihezi University · CNThe University of Texas Southwestern Medical Center · USUniversity of Helsinki · FIUniversity of Zambia · ZMYonsei University · KR

Funding

ROLES OF CD66 ANTIGENS IN INFECTION BY N GONORRHOEAER01AI047736 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CHEN, TIE · 1999 to 2003
$668k
NIAID NIH HHS R01 AI047736
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EndocytosisHost-Pathogen InteractionsAnimalsBacterial AdhesionCell Adhesion MoleculesCells, CulturedDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsDisease Models, AnimalHumansLectins, C-TypeLipopolysaccharidesMacrophagesMice, Inbred BALB CMice, Inbred C57BLProtein BindingCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinLectins, C-TypeLipopolysaccharidesReceptors, Cell SurfaceCD209aCD209bDCsDC-SIGNdendritic cellsdisseminationlipopolysaccharide coreLPS coreSIGN-R1Yersinia pseudotuberculosis

Identifiers

PMID30348825
PMCPMC6300620
OpenAlexW2896213368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.